WNT5A-JNK regulation of vascular insulin resistance in human obesity

Vascular Medicine (United Kingdom)

Volumn 21, Issue 6, 2016, Pages 489-496

  Farb, Melissa G ^a   Karki, Shakun ^a   Park, Song Young ^a   Saggese, Samantha M ^a   Carmine, Brian ^b   Hess, Donald T ^b   Apovian, Caroline ^b   Fetterman, Jessica L ^a   Bretón Romero, Rosa ^a   Hamburg, Naomi M ^a   Fuster, José J ^a   Zuriaga, María A ^a   Walsh, Kenneth ^a   Gokce, Noyan ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endothelium; insulin resistance; nitric oxide; obesity

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; STRESS ACTIVATED PROTEIN KINASE; WNT5A PROTEIN; INSULIN; NOS3 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; VASODILATOR AGENT; WNT5A PROTEIN, HUMAN;

ADIPOSE TISSUE; ADULT; ARTERIOLE; ARTICLE; BODY MASS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INSULIN RESISTANCE; INTRAPERITONEAL FAT; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR INSULIN RESISTANCE; VIDEO MICROSCOPY; WESTERN BLOTTING; WNT5A GENE; ADOLESCENT; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; IN VITRO STUDY; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHOSPHORYLATION; VASCULARIZATION; VASODILATATION; WNT SIGNALING PATHWAY; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; ARTERIOLES; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IN VITRO TECHNIQUES; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; VASODILATION; VASODILATOR AGENTS; WNT SIGNALING PATHWAY; WNT-5A PROTEIN; YOUNG ADULT;

EID: 84999106880     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X16666693     Document Type: Article

References (50)

1. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129: S102-138.
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781.
3. Muniyappa R, Montagnani M, Koh KK, et al. Cardiovascular actions of insulin. Endocr Rev 2007; 28: 463-491.
4. Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
5. Farb MG, Ganley-Leal L, Mott M, et al. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol 2012; 32: 467-473.
6. Farb MG, Gokce N,. Visceral adiposopathy: A vascular perspective. Horm Mol Biol Clin Investig 2015; 21: 125-136.
7. Farb MG, Tiwari S, Karki S, et al. Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity (Silver Spring) 2014; 22: 349-355.
8. Hashimoto M, Akishita M, Eto M, et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 1998; 22: 477-484.
9. Parikh NI, Keyes MJ, Larson MG, et al. Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) 2009; 17: 2054-2059.
10. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007; 116: 1234-1241.
11. Breton-Romero R, Feng B, Holbrook M, et al. Endothelial dysfunction in human diabetes is mediated by Wnt5a-JNK signaling. Arterioscler Thromb Vasc Biol 2016; 36: 561-569.
12. Fuster JJ, Zuriaga MA, Ngo DT, et al. Noncanonical wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion. Diabetes 2015; 64: 1235-1248.
13. Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010; 329: 454-457.
14. Arnold AC, Robertson D,. Defective Wnt signaling: A potential contributor to cardiometabolic disease? Diabetes 2015; 64: 3342-3344.
15. Kikuchi A, Yamamoto H, Sato A, et al. Wnt5a: Its signalling, functions and implication in diseases. Acta Physiol (Oxf) 2012; 204: 17-33.
16. Bhatt PM, Malgor R,. Wnt5a: A player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis 2014; 237: 155-162.
17. Catalan V, Gomez-Ambrosi J, Rodriguez A, et al. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. J Clin Endocrinol Metab 2014; 99: E1407-1417.
18. Christman MA, Goetz DJ, Dickerson E, et al. Wnt5a is expressed in murine and human atherosclerotic lesions. Am J Physiol Heart Circ Physiol 2008; 294: H2864-H2870.
19. Miyoshi T, Doi M, Usui S, et al. Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease. Atherosclerosis 2014; 233: 454-459.
20. Schulte DM, Muller N, Neumann K, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoSOne 2012; 7: e32437.
21. Tabit CE, Shenouda SM, Holbrook M, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation 2013; 127: 86-95.
22. Fetterman JL, Holbrook M, Flint N, et al. Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling. Atherosclerosis 2016; 247: 207-217.
23. Karki S, Farb MG, Ngo DT, et al. Forkhead box o-1 modulation improves endothelial insulin resistance in human obesity. Arterioscler Thromb Vasc Biol 2015; 35: 1498-1506.
24. Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications. Rev Endocr Metab Disord 2010; 11: 61-74.
25. Han MS, Jung DY, Morel C, et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013; 339: 218-222.
26. Solinas G, Vilcu C, Neels JG, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007; 6: 386-397.
27. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.
28. Luo Z, Fujio Y, Kureishi Y, et al. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Investig 2000; 106: 493-499.
29. Alvehus M, Buren J, Sjostrom M, et al. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010; 18: 879-883.
30. Lee MJ, Wu Y, Fried SK,. Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 2013; 34: 1-11.
31. Despres JP,. Body fat distribution and risk of cardiovascular disease: An update. Circulation 2012; 126: 1301-1313.
32. Kikuchi R, Nakamura K, MacLauchlan S, et al. An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease. Nat Med 2014; 20: 1464-1471.
33. Gao B, Song H, Bishop K, et al. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell 2011; 20: 163-176.
34. Oishi I, Suzuki H, Onishi N, et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 2003; 8: 645-654.
35. Nomachi A, Nishita M, Inaba D, et al. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 2008; 283: 27,973-27,981.
36. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-336.
37. Sabio G, Das M, Mora A, et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008; 322: 1539-1543.
38. Sumara G, Belwal M, Ricci R,. 'Jnking' atherosclerosis. Cell Mol Life Sci 2005; 62: 2487-2494.
39. Virdis A, Duranti E, Rossi C, et al. Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: Role of perivascular adipose tissue. Eur Heart J 2015; 36: 784-794.
40. Bashan N, Dorfman K, Tarnovscki T, et al. Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 2007; 148: 2955-2962.
41. Nishio H, Matsui K, Tsuji H, et al. Immunohistochemical study of the phosphorylated and activated form of c-Jun NH2-terminal kinase in human aorta. Histochem J 2001; 33: 167-171.
42. Jiang ZY, Lin YW, Clemont A, et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999; 104: 447-457.
43. Rask-Madsen C, Li Q, Freund B, et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 2010; 11: 379-389.
44. Steinberg HO, Brechtel G, Johnson A, et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179.
45. Steinberg HO, Chaker H, Leaming R, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Investig 1996; 97: 2601-2610.
46. Virdis A, Santini F, Colucci R, et al. Vascular generation of tumor necrosis factor-alpha reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011; 58: 238-247.
47. Dharmashankar K, Welsh A, Wang J, et al. Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measurements of endothelial function. Am J Hypertens 2012; 25: 528-534.
48. Truran S, Franco DA, Roher AE, et al. Adipose and leptomeningeal arteriole endothelial dysfunction induced by beta-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy. J Neurosci Methods 2014; 235: 123-129.
49. Longitudinal Assessment of Bariatric Surgery Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445-454.
50. Bigornia SJ, Farb MG, Tiwari S, et al. Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol 2013; 62: 2297-2305.